Non-Small Cell Carcinoma of Lung, TNM Stage 4 Clinical Trial
Official title:
TRUMPRWS: A Non-interventional Study on Genetic Variants and Its Clinical Relevance in Chinese Patients With Advanced NSCLC (TRUMPRWS)
This is a descriptive observational study, in which data are collected in an epidemiological fashion. This study does not intend to alter or intervene the current medical practice of the recruited patients. Data will be collected in prospective manner.
This is a descriptive observational study, in which data are collected in an epidemiological
fashion. This study does not intend to alter or intervene the current medical practice of the
recruited patients. Data will be collected in prospective manner.
The eligible patients will be recruited after NGS analysis for tumor tissue and the
inform-consent is obtained. The study required information will be collected (every 3
months).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03786692 -
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
|
Phase 2 | |
| Completed |
NCT04776083 -
Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients
|
Phase 3 | |
| Active, not recruiting |
NCT03288870 -
Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS)
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05919264 -
FOG-001 in Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03042221 -
Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy
|
||
| Recruiting |
NCT05274451 -
A Study to Investigate LYL797 in Adults With Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT05372081 -
Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer
|
||
| Recruiting |
NCT03774732 -
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
|
Phase 3 | |
| Completed |
NCT03406468 -
Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer
|
Phase 2 | |
| Recruiting |
NCT04856176 -
A Study of Sargramostim Plus Pembrolizumab With or Without Pemetrexed in Patients With Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy
|
Phase 2 | |
| Completed |
NCT04710459 -
Endobronchial Cryotherapy in Management of MEBO in Patients With Inoperable NSCLC
|
N/A | |
| Terminated |
NCT02967133 -
A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer
|
Phase 2 |